Breast Fibroadenoma
FDA approved targeted cryoablation for treatment of breast fibroadenoma in 2003. Clinical data provided by Dr. Peter Littrup from Karmanos Cancer Research Institute, Detroit, USA proved some features of targeted cryoablation of benign breast fibroadenoma: rapid absorption, no pain, simple operation, enhanced immuno-response.
ENDOCARE, Inc. predicts that targeted cryoablation can help up to 500,000 patients of benign breast fibroadenoma to get rid of painful conventional operations and psychological pressure by preserving the shape of a breast.
Breast fibroadenoma Treatment Review
· Investigation of breast fibroadenoma treatment proves: there is no apparent distinction between curative effect of radical resection and that of breast-conserving surgery.
· Breast cancer sufferers have a strong desire to pursue good life-style while keep cancers away.
Terminal Pelvic Tumor
Targeted cryoablation has achieved satisfactory clinical curative effect in treatment of cervical cancer, uterine fibroids and unresectable ovary cancer.
Uterine Myomas
Cryosurgery performed by laparoscopic or percutaneous routes ,off one option for uterine fibroids. Several feasibility studies have been carried out using this approach to treat subserosal and intramural myomas ,each yielding promising results. The procedure involves freezing the tumors under direct guidance of real-time ultrasound or laparoscopy .In contrast to other approaches to ablation ,cryoablation can usually be accomplished without cervical dilation and with little or no anesthesia. |
